Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 8/2011

01-12-2011 | Review Article

Molecular pathogenesis of nodular goiter

Author: Ralf Paschke

Published in: Langenbeck's Archives of Surgery | Issue 8/2011

Login to get access

Abstract

Introduction

Familial clustering of goiters mostly with an autosomal dominant pattern of inheritance has repeatedly been reported. Moreover, other environmental and etiologic factors are likely to be involved in the development of euthyroid goiter. Therefore, a multifactorial etiology based on complex interactions of both genetic predisposition and the individuals’ environment is likely.

Methods

The line of events from early thyroid hyperplasia to multinodular goiter argues for the predominant neoplastic (i.e., originating from a single mutated cell) character of nodular structures. Etiologically, relevant somatic mutations are known in two thirds of papillary and follicular thyroid carcinomas and hot thyroid nodules. In contrast, the somatic mutations relevant for benign cold or benign isocaptant thyroid nodules which constitute the majority of thyroid nodules are unknown.

Results

The nodular process is triggered by the oxidative nature of thyroid hormone synthesis or additional oxidative stress caused by iodine deficiency or smoking. If the antioxidant defense is not effective, this oxidative stress will cause DNA damage followed by an increase of the spontaneous mutation rate which is a substrate for tumorogenesis.

Conclusions

Therefore, the hallmark of thyroid physiology—H2O2 production during hormone synthesis—is very likely the ultimate cause for the frequent mutagenesis in the thyroid gland. Because iodine deficiency increases the oxidative burden, DNA damage and mutagenesis could provide the basis for the frequent nodular transformation of endemic goiters.
Literature
1.
go back to reference Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911PubMedCrossRef Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911PubMedCrossRef
2.
go back to reference Belfiore A, La Rosa GL, La Porta GA et al (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363–369PubMedCrossRef Belfiore A, La Rosa GL, La Porta GA et al (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363–369PubMedCrossRef
3.
go back to reference Knudsen N, Perrild H, Christiansen E et al (2000) Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 142:224–230PubMedCrossRef Knudsen N, Perrild H, Christiansen E et al (2000) Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 142:224–230PubMedCrossRef
4.
go back to reference Chan JKC, Hirokawa M, Evans H, Williams ED, Osamura Y, Cady B, Sobrinho-Simoes M, Derwahl M, Paschke R, Belge G, Oriola J, Studer H, Eng C, Asa SL, Lloyd RV, Baloch Z, Ghossein R, Fagin JA (2004) Follicular adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, pp 98–103 Chan JKC, Hirokawa M, Evans H, Williams ED, Osamura Y, Cady B, Sobrinho-Simoes M, Derwahl M, Paschke R, Belge G, Oriola J, Studer H, Eng C, Asa SL, Lloyd RV, Baloch Z, Ghossein R, Fagin JA (2004) Follicular adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, pp 98–103
5.
go back to reference Berghout A, Wiersinga WM, Smits NJ et al (1990) Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 89:602–608PubMedCrossRef Berghout A, Wiersinga WM, Smits NJ et al (1990) Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 89:602–608PubMedCrossRef
6.
go back to reference Knudsen N, Laurberg P, Perrild H et al (2002) Risk factors for goiter and thyroid nodules. Thyroid 12:879–888PubMedCrossRef Knudsen N, Laurberg P, Perrild H et al (2002) Risk factors for goiter and thyroid nodules. Thyroid 12:879–888PubMedCrossRef
7.
go back to reference Pisarikova B, Herzig I, Riha J (1996) Inorganic anions with a potential goitrogenic effect in drinking water supply for humans and animals. Vet Med (Praha) 41:33–39 Pisarikova B, Herzig I, Riha J (1996) Inorganic anions with a potential goitrogenic effect in drinking water supply for humans and animals. Vet Med (Praha) 41:33–39
8.
go back to reference Scanelli G (2002) Lithium thyrotoxicosis. Report of a case and review of the literature. Recenti Prog Med 93:100–103PubMed Scanelli G (2002) Lithium thyrotoxicosis. Report of a case and review of the literature. Recenti Prog Med 93:100–103PubMed
9.
go back to reference Brix TH, Hansen PS, Kyvik KO et al (2000) Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med 160:661–666PubMedCrossRef Brix TH, Hansen PS, Kyvik KO et al (2000) Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med 160:661–666PubMedCrossRef
10.
go back to reference Brix TH, Kyvik KO, Hegedus L (1999) Major role of genes in the etiology of simple goiter in females: a population-based twin study. J Clin Endocrinol Metab 84:3071–3075PubMedCrossRef Brix TH, Kyvik KO, Hegedus L (1999) Major role of genes in the etiology of simple goiter in females: a population-based twin study. J Clin Endocrinol Metab 84:3071–3075PubMedCrossRef
11.
go back to reference Knudsen N, Bulow I, Laurberg P et al (2002) Parity is associated with increased thyroid volume solely among smokers in an area with moderate to mild iodine deficiency. Eur J Endocrinol 146:39–43PubMedCrossRef Knudsen N, Bulow I, Laurberg P et al (2002) Parity is associated with increased thyroid volume solely among smokers in an area with moderate to mild iodine deficiency. Eur J Endocrinol 146:39–43PubMedCrossRef
12.
go back to reference Krohn K, Fuhrer D, Bayer Y et al (2005) Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504–524PubMedCrossRef Krohn K, Fuhrer D, Bayer Y et al (2005) Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504–524PubMedCrossRef
13.
go back to reference Hansen PS, Brix TH, Bennedbaek FN et al (2004) Genetic and environmental causes of individual differences in thyroid size: a study of healthy Danish twins. J Clin Endocrinol Metab 89:2071–2077PubMedCrossRef Hansen PS, Brix TH, Bennedbaek FN et al (2004) Genetic and environmental causes of individual differences in thyroid size: a study of healthy Danish twins. J Clin Endocrinol Metab 89:2071–2077PubMedCrossRef
14.
go back to reference Bayer Y, Neumann S, Meyer B et al (2004) Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. J Clin Endocrinol Metab 89:4044–4052PubMedCrossRef Bayer Y, Neumann S, Meyer B et al (2004) Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. J Clin Endocrinol Metab 89:4044–4052PubMedCrossRef
15.
go back to reference Bignell GR, Canzian F, Shayeghi M et al (1997) Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123–1130PubMedCrossRef Bignell GR, Canzian F, Shayeghi M et al (1997) Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123–1130PubMedCrossRef
16.
go back to reference Neumann S, Bayer Y, Reske A et al (2003) Further indications for genetic heterogeneity of euthyroid familial goiter. J Mol Med 81:736–745PubMedCrossRef Neumann S, Bayer Y, Reske A et al (2003) Further indications for genetic heterogeneity of euthyroid familial goiter. J Mol Med 81:736–745PubMedCrossRef
17.
go back to reference Brix TH, Hegedüs L (2000) Genetic and environmental factors in the aetiology of simple goitre. Ann Med 32:153–156PubMedCrossRef Brix TH, Hegedüs L (2000) Genetic and environmental factors in the aetiology of simple goitre. Ann Med 32:153–156PubMedCrossRef
18.
go back to reference Geerdsen JP, Hee P (1982) Nontoxic goitre. I. Surgical complications and longterm prognosis. Acta Chir Scand 148:221–224PubMed Geerdsen JP, Hee P (1982) Nontoxic goitre. I. Surgical complications and longterm prognosis. Acta Chir Scand 148:221–224PubMed
19.
go back to reference Piraneo S, Vitri P, Galimberti A et al (1997) Ultrasonographic surveillance after surgery for euthyroid goitre in patients treated or not with thyroxine. Eur J Surg 163:21–26PubMed Piraneo S, Vitri P, Galimberti A et al (1997) Ultrasonographic surveillance after surgery for euthyroid goitre in patients treated or not with thyroxine. Eur J Surg 163:21–26PubMed
20.
go back to reference Corral J, Martin C, Perez R et al (1993) Thyroglobulin gene point mutation associated with non-endemic simple goitre. Lancet 341:462–464PubMedCrossRef Corral J, Martin C, Perez R et al (1993) Thyroglobulin gene point mutation associated with non-endemic simple goitre. Lancet 341:462–464PubMedCrossRef
21.
go back to reference Gonzalez-Sarmiento R, Corral J, Mories MT et al (2001) Monoallelic deletion in the 5' region of the thyroglobulin gene as a cause of sporadic nonendemic simple goiter. Thyroid 11:789–793PubMedCrossRef Gonzalez-Sarmiento R, Corral J, Mories MT et al (2001) Monoallelic deletion in the 5' region of the thyroglobulin gene as a cause of sporadic nonendemic simple goiter. Thyroid 11:789–793PubMedCrossRef
22.
go back to reference Everett LA, Glaser B, Beck JC et al (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17:411–422PubMedCrossRef Everett LA, Glaser B, Beck JC et al (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17:411–422PubMedCrossRef
23.
go back to reference Masmoudi S, Charfedine I, Hmani M et al (2000) Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation. Am J Med Genet 90:38–44PubMedCrossRef Masmoudi S, Charfedine I, Hmani M et al (2000) Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation. Am J Med Genet 90:38–44PubMedCrossRef
24.
go back to reference Fujiwara H, Tatsumi K, Miki K et al (1998) Recurrent T354P mutation of the Na+/I- symporter in patients with iodide transport defect. J Clin Endocrinol Metab 83:2940–2943PubMedCrossRef Fujiwara H, Tatsumi K, Miki K et al (1998) Recurrent T354P mutation of the Na+/I- symporter in patients with iodide transport defect. J Clin Endocrinol Metab 83:2940–2943PubMedCrossRef
25.
go back to reference Matsuda A, Kosugi S (1997) A homozygous missense mutation of the sodium /iodide symporter gene causing iodide transport defect. J Clin Endocrinol Metab 82:3966–3971PubMedCrossRef Matsuda A, Kosugi S (1997) A homozygous missense mutation of the sodium /iodide symporter gene causing iodide transport defect. J Clin Endocrinol Metab 82:3966–3971PubMedCrossRef
26.
go back to reference Neumann S, Willgerodt H, Ackermann F et al (1999) Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na+/I- symporter. J Clin Endocrinol Metab 84:3750–3756 [In Process Citation]PubMedCrossRef Neumann S, Willgerodt H, Ackermann F et al (1999) Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na+/I- symporter. J Clin Endocrinol Metab 84:3750–3756 [In Process Citation]PubMedCrossRef
27.
go back to reference Capon F, Tacconelli A, Giardina E et al (2000) Mapping a dominant form of multinodular goiter to chromosome Xp22. Am J Hum Genet 67:1004–1007PubMedCrossRef Capon F, Tacconelli A, Giardina E et al (2000) Mapping a dominant form of multinodular goiter to chromosome Xp22. Am J Hum Genet 67:1004–1007PubMedCrossRef
28.
go back to reference Many MC, Denef JF, Hamudi S et al (1986) Effects of iodide and thyroxine on iodine-deficient mouse thyroid: a morphological and functional study. J Endocrinol 110:203–210PubMedCrossRef Many MC, Denef JF, Hamudi S et al (1986) Effects of iodide and thyroxine on iodine-deficient mouse thyroid: a morphological and functional study. J Endocrinol 110:203–210PubMedCrossRef
29.
go back to reference Raspe E, Dumont JE (1995) Tonic modulation of dog thyrocyte H2O2 generation and I- uptake by thyrotropin through the cyclic adenosine 3',5'-monophosphate cascade. Endocrinology 136:965–973PubMedCrossRef Raspe E, Dumont JE (1995) Tonic modulation of dog thyrocyte H2O2 generation and I- uptake by thyrotropin through the cyclic adenosine 3',5'-monophosphate cascade. Endocrinology 136:965–973PubMedCrossRef
30.
go back to reference Krohn K, Wohlgemuth S, Gerber H et al (2000) Hot microscopic areas of iodine deficient euthyroid goiters contain constitutively activating TSH receptor mutations. J Pathol 192:37–42PubMedCrossRef Krohn K, Wohlgemuth S, Gerber H et al (2000) Hot microscopic areas of iodine deficient euthyroid goiters contain constitutively activating TSH receptor mutations. J Pathol 192:37–42PubMedCrossRef
31.
go back to reference Abs R, Stevenaert A, Beckers A (1994) Autonomously functioning thyroid nodules in a patient with a thyrotropin-secreting pituitary adenoma: possible cause–effect relationship. Eur J Endocrinol 131:355–358PubMedCrossRef Abs R, Stevenaert A, Beckers A (1994) Autonomously functioning thyroid nodules in a patient with a thyrotropin-secreting pituitary adenoma: possible cause–effect relationship. Eur J Endocrinol 131:355–358PubMedCrossRef
32.
go back to reference Studer H, Huber G, Derwahl M et al (1989) The transformation of Basedow's struma into nodular goiter: a reason for recurrence of hyperthyroidism. Schweiz Med Wochenschr 119:203–208PubMed Studer H, Huber G, Derwahl M et al (1989) The transformation of Basedow's struma into nodular goiter: a reason for recurrence of hyperthyroidism. Schweiz Med Wochenschr 119:203–208PubMed
33.
go back to reference Cheung NW, Boyages SC (1997) The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46:545–549CrossRef Cheung NW, Boyages SC (1997) The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46:545–549CrossRef
34.
go back to reference Dumont JE, Ermans AM, Maenhaut C et al (1995) Large goitre as a maladaptation to iodine deficiency. Clin Endocrinol (Oxf) 43:1–10CrossRef Dumont JE, Ermans AM, Maenhaut C et al (1995) Large goitre as a maladaptation to iodine deficiency. Clin Endocrinol (Oxf) 43:1–10CrossRef
35.
go back to reference Maier J, Van SH, Van OC et al (2007) Iodine deficiency activates antioxidant genes and causes DNA damage in the thyroid gland of rats and mice. Biochim Biophys Acta 1773:990–999PubMedCrossRef Maier J, Van SH, Van OC et al (2007) Iodine deficiency activates antioxidant genes and causes DNA damage in the thyroid gland of rats and mice. Biochim Biophys Acta 1773:990–999PubMedCrossRef
36.
go back to reference Gerard AC, Poncin S, Caetano B et al (2008) Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid. Am J Pathol 172:748–760PubMedCrossRef Gerard AC, Poncin S, Caetano B et al (2008) Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid. Am J Pathol 172:748–760PubMedCrossRef
37.
go back to reference Howie AF, Arthur JR, Nicol F et al (1998) Identification of a 57-kilodalton selenoprotein in human thyrocytes as thioredoxin reductase and evidence that its expression is regulated through the calcium-phosphoinositol signaling pathway. J Clin Endocrinol Metab 83:2052–2058PubMedCrossRef Howie AF, Arthur JR, Nicol F et al (1998) Identification of a 57-kilodalton selenoprotein in human thyrocytes as thioredoxin reductase and evidence that its expression is regulated through the calcium-phosphoinositol signaling pathway. J Clin Endocrinol Metab 83:2052–2058PubMedCrossRef
38.
go back to reference Howie AF, Walker SW, Akesson B et al (1995) Thyroidal extracellular glutathione peroxidase: a potential regulator of thyroid-hormone synthesis. Biochem J 308:713–717PubMed Howie AF, Walker SW, Akesson B et al (1995) Thyroidal extracellular glutathione peroxidase: a potential regulator of thyroid-hormone synthesis. Biochem J 308:713–717PubMed
39.
go back to reference Demelash A, Karlsson JO, Nilsson M et al (2004) Selenium has a protective role in caspase-3-dependent apoptosis induced by H2O2 in primary cultured pig thyrocytes. Eur J Endocrinol 150:841–849PubMedCrossRef Demelash A, Karlsson JO, Nilsson M et al (2004) Selenium has a protective role in caspase-3-dependent apoptosis induced by H2O2 in primary cultured pig thyrocytes. Eur J Endocrinol 150:841–849PubMedCrossRef
40.
go back to reference Krohn K, Maier J, Paschke R (2007) Mechanisms of disease: hydrogen peroxide. DNA damage and mutagenesis in the development of thyroid tumors. Nat Clin Pract Endocrinol Metab 3:713–720PubMedCrossRef Krohn K, Maier J, Paschke R (2007) Mechanisms of disease: hydrogen peroxide. DNA damage and mutagenesis in the development of thyroid tumors. Nat Clin Pract Endocrinol Metab 3:713–720PubMedCrossRef
41.
go back to reference Maier J, Van SH, Van OC et al (2006) Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 147:3391–3397PubMedCrossRef Maier J, Van SH, Van OC et al (2006) Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 147:3391–3397PubMedCrossRef
42.
go back to reference van Steeg H, Mullenders LH, Vijg J (2000) Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice. Mutat Res 450:167–180PubMedCrossRef van Steeg H, Mullenders LH, Vijg J (2000) Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice. Mutat Res 450:167–180PubMedCrossRef
43.
go back to reference Cardoso LC, Martins DC, Figueiredo MD et al (2001) Ca(2+)/nicotinamide adenine dinucleotide phosphate-dependent H(2)O(2) generation is inhibited by iodide in human thyroids. J Clin Endocrinol Metab 86:4339–4343PubMedCrossRef Cardoso LC, Martins DC, Figueiredo MD et al (2001) Ca(2+)/nicotinamide adenine dinucleotide phosphate-dependent H(2)O(2) generation is inhibited by iodide in human thyroids. J Clin Endocrinol Metab 86:4339–4343PubMedCrossRef
44.
go back to reference Cooke MS, Evans MD, Dizdaroglu M et al (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214PubMedCrossRef Cooke MS, Evans MD, Dizdaroglu M et al (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214PubMedCrossRef
45.
go back to reference Poncin S, Gerard AC, Boucquey M et al (2008) Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 149:424–433PubMedCrossRef Poncin S, Gerard AC, Boucquey M et al (2008) Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 149:424–433PubMedCrossRef
46.
go back to reference Parma J, Duprez L, Van Sande J et al (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649–651PubMedCrossRef Parma J, Duprez L, Van Sande J et al (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649–651PubMedCrossRef
47.
go back to reference Führer D, Holzapfel HP, Wonerow P et al (1997) Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885–3891PubMedCrossRef Führer D, Holzapfel HP, Wonerow P et al (1997) Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885–3891PubMedCrossRef
48.
go back to reference Georgopoulos NA, Sykiotis GP, Sgourou A et al (2003) Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway. Eur J Endocrinol 149:287–292PubMedCrossRef Georgopoulos NA, Sykiotis GP, Sgourou A et al (2003) Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway. Eur J Endocrinol 149:287–292PubMedCrossRef
49.
go back to reference Gozu HI, Bircan R, Krohn K et al (2006) Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol 155:535–545PubMedCrossRef Gozu HI, Bircan R, Krohn K et al (2006) Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol 155:535–545PubMedCrossRef
51.
go back to reference Krohn K, Paschke R (2001) Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab 86:3336–3345PubMedCrossRef Krohn K, Paschke R (2001) Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab 86:3336–3345PubMedCrossRef
52.
go back to reference Garcia-Delgado M, Gonzalez-Navarro CJ, Napal MC et al (1998) Higher sensitivity of denaturing gradient gel electrophoresis than sequencing in the detection of mutations in DNA from tumor samples. Biotechniques 24:72–74, 76PubMed Garcia-Delgado M, Gonzalez-Navarro CJ, Napal MC et al (1998) Higher sensitivity of denaturing gradient gel electrophoresis than sequencing in the detection of mutations in DNA from tumor samples. Biotechniques 24:72–74, 76PubMed
53.
go back to reference Trulzsch B, Krohn K, Wonerow P et al (1999) DGGE is more sensitive for the detection of somatic point mutations than direct sequencing. Biotechniques 27:266–268PubMed Trulzsch B, Krohn K, Wonerow P et al (1999) DGGE is more sensitive for the detection of somatic point mutations than direct sequencing. Biotechniques 27:266–268PubMed
54.
go back to reference Trülzsch B, Krohn K, Wonerow P et al (2001) Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 78:684–691PubMedCrossRef Trülzsch B, Krohn K, Wonerow P et al (2001) Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 78:684–691PubMedCrossRef
55.
go back to reference Van Sande J, Parma J, Tonacchera M et al (1995) Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 80:2577–2585PubMedCrossRef Van Sande J, Parma J, Tonacchera M et al (1995) Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 80:2577–2585PubMedCrossRef
56.
go back to reference Dugrillon A, Bechtner G, Uedelhoven WM et al (1990) Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3',5'-monophosphate formation. Endocrinology 127:337–343PubMedCrossRef Dugrillon A, Bechtner G, Uedelhoven WM et al (1990) Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3',5'-monophosphate formation. Endocrinology 127:337–343PubMedCrossRef
57.
go back to reference Roger PP, Servais P, Dumont JE (1983) Stimulation by thyrotropin and cyclic AMP of the proliferation of quiescent canine thyroid cells cultured in a defined medium containing insulin. FEBS Lett 157:323–329PubMedCrossRef Roger PP, Servais P, Dumont JE (1983) Stimulation by thyrotropin and cyclic AMP of the proliferation of quiescent canine thyroid cells cultured in a defined medium containing insulin. FEBS Lett 157:323–329PubMedCrossRef
58.
go back to reference Eggo MC, Bachrach LK, Burrow GN (1990) Interaction of TSH, insulin and insulin-like growth factors in regulating thyroid growth and function. Growth Factors 2:99–109PubMedCrossRef Eggo MC, Bachrach LK, Burrow GN (1990) Interaction of TSH, insulin and insulin-like growth factors in regulating thyroid growth and function. Growth Factors 2:99–109PubMedCrossRef
59.
go back to reference Eszlinger M, Krohn K, Frenzel R et al (2004) Gene expression analysis reveals evidence for inactivation of the TGF-beta signaling cascade in autonomously functioning thyroid nodules. Oncogene 23:795–804PubMedCrossRef Eszlinger M, Krohn K, Frenzel R et al (2004) Gene expression analysis reveals evidence for inactivation of the TGF-beta signaling cascade in autonomously functioning thyroid nodules. Oncogene 23:795–804PubMedCrossRef
60.
go back to reference Gärtner R, Schopohl D, Schaefer S et al (1997) Regulation of transforming growth factor beta 1 messenger ribonucleic acid expression in porcine thyroid follicles in vitro by growth factors, iodine, or delta-iodolactone. Thyroid 7:633–640PubMedCrossRef Gärtner R, Schopohl D, Schaefer S et al (1997) Regulation of transforming growth factor beta 1 messenger ribonucleic acid expression in porcine thyroid follicles in vitro by growth factors, iodine, or delta-iodolactone. Thyroid 7:633–640PubMedCrossRef
61.
go back to reference Taton M, Lamy F, Roger PP et al (1993) General inhibition by transforming growth factor beta 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture. Mol Cell Endocrinol 95:13–21PubMedCrossRef Taton M, Lamy F, Roger PP et al (1993) General inhibition by transforming growth factor beta 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture. Mol Cell Endocrinol 95:13–21PubMedCrossRef
62.
go back to reference Depoortere F, Pirson I, Bartek J et al (2000) Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol Biol Cell 11:1061–1076PubMed Depoortere F, Pirson I, Bartek J et al (2000) Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol Biol Cell 11:1061–1076PubMed
63.
go back to reference Grubeck-Loebenstein B, Buchan G, Sadeghi R et al (1989) Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. J Clin Invest 83:764–770PubMedCrossRef Grubeck-Loebenstein B, Buchan G, Sadeghi R et al (1989) Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. J Clin Invest 83:764–770PubMedCrossRef
64.
go back to reference Krohn K, Emmrich P, Ott N et al (1999) Increased thyroid epithelial cell proliferation in toxic thyroid nodules. Thyroid 9:241–246PubMedCrossRef Krohn K, Emmrich P, Ott N et al (1999) Increased thyroid epithelial cell proliferation in toxic thyroid nodules. Thyroid 9:241–246PubMedCrossRef
65.
go back to reference Derwahl M, Studer H (2001) Nodular goiter and goiter nodules: where iodine deficiency falls short of explaining the facts. Exp Clin Endocrinol Diabetes 109:250–260PubMedCrossRef Derwahl M, Studer H (2001) Nodular goiter and goiter nodules: where iodine deficiency falls short of explaining the facts. Exp Clin Endocrinol Diabetes 109:250–260PubMedCrossRef
66.
go back to reference Studer H, Peter HJ, Gerber H (1989) Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocr Rev 10:125–135PubMedCrossRef Studer H, Peter HJ, Gerber H (1989) Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocr Rev 10:125–135PubMedCrossRef
67.
go back to reference Krohn K, Reske A, Ackermann F et al (2001) Ras mutations are rare in solitary cold and toxic thyroid nodules. Clin Endocrinol 55:241–248CrossRef Krohn K, Reske A, Ackermann F et al (2001) Ras mutations are rare in solitary cold and toxic thyroid nodules. Clin Endocrinol 55:241–248CrossRef
68.
go back to reference Dohan O, Baloch Z, Banrevi Z et al (2001) Rapid communication: predominant intracellular overexpression of the Na(+)/I(−) symporter (NIS) in a large sampling of thyroid cancer cases. J Clin Endocrinol Metab 86:2697–2700PubMedCrossRef Dohan O, Baloch Z, Banrevi Z et al (2001) Rapid communication: predominant intracellular overexpression of the Na(+)/I(−) symporter (NIS) in a large sampling of thyroid cancer cases. J Clin Endocrinol Metab 86:2697–2700PubMedCrossRef
69.
go back to reference Dohan O, De la Vieja A, Paroder V et al (2003) The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48–77PubMedCrossRef Dohan O, De la Vieja A, Paroder V et al (2003) The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48–77PubMedCrossRef
70.
go back to reference Tonacchera M, Viacava P, Agretti P et al (2002) Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. J Clin Endocrinol Metab 87:352–357PubMedCrossRef Tonacchera M, Viacava P, Agretti P et al (2002) Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. J Clin Endocrinol Metab 87:352–357PubMedCrossRef
71.
72.
go back to reference Lazar V, Bidart JM, Caillou B et al (1999) Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228–3234PubMedCrossRef Lazar V, Bidart JM, Caillou B et al (1999) Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228–3234PubMedCrossRef
73.
go back to reference Caillou B, Dupuy C, Lacroix L et al (2001) Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues. J Clin Endocrinol Metab 86:3351–3358PubMedCrossRef Caillou B, Dupuy C, Lacroix L et al (2001) Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues. J Clin Endocrinol Metab 86:3351–3358PubMedCrossRef
74.
go back to reference De Vijlder JJ (2003) Primary congenital hypothyroidism: defects in iodine pathways. Eur J Endocrinol 149:247–256PubMedCrossRef De Vijlder JJ (2003) Primary congenital hypothyroidism: defects in iodine pathways. Eur J Endocrinol 149:247–256PubMedCrossRef
75.
go back to reference Pisarev MA, Krawiec L, Juvenal GJ et al (1994) Studies on the goiter inhibiting action of iodolactones. Eur J Pharmacol 258:33–37PubMedCrossRef Pisarev MA, Krawiec L, Juvenal GJ et al (1994) Studies on the goiter inhibiting action of iodolactones. Eur J Pharmacol 258:33–37PubMedCrossRef
76.
go back to reference Krohn K, Paschke R (2001) Loss of heterozygocity at the thyroid peroxidase gene locus in solitary cold thyroid nodules. Thyroid 11:741–747PubMedCrossRef Krohn K, Paschke R (2001) Loss of heterozygocity at the thyroid peroxidase gene locus in solitary cold thyroid nodules. Thyroid 11:741–747PubMedCrossRef
77.
go back to reference Krohn K, Paschke R (2004) BRAF mutations are not an alternative explanation for the molecular etiology of ras-mutation negative cold thyroid nodules. Thyroid 14:359–361PubMedCrossRef Krohn K, Paschke R (2004) BRAF mutations are not an alternative explanation for the molecular etiology of ras-mutation negative cold thyroid nodules. Thyroid 14:359–361PubMedCrossRef
78.
go back to reference Xing M, Vasko V, Tallini G et al (2004) BRAF T1796A transversion mutation in various thyroid neoplasms. J Clin Endocrinol Metab 89:1365–1368PubMedCrossRef Xing M, Vasko V, Tallini G et al (2004) BRAF T1796A transversion mutation in various thyroid neoplasms. J Clin Endocrinol Metab 89:1365–1368PubMedCrossRef
79.
go back to reference Puxeddu E, Moretti S, Elisei R et al (2004) BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab 89:2414–2420PubMedCrossRef Puxeddu E, Moretti S, Elisei R et al (2004) BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab 89:2414–2420PubMedCrossRef
80.
go back to reference Soares P, Trovisco V, Rocha AS et al (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578–4580PubMedCrossRef Soares P, Trovisco V, Rocha AS et al (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578–4580PubMedCrossRef
81.
go back to reference Eszlinger M, Krohn K, Berger K et al (2005) Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. J Clin Endocrinol Metab 90:1163–1170PubMedCrossRef Eszlinger M, Krohn K, Berger K et al (2005) Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. J Clin Endocrinol Metab 90:1163–1170PubMedCrossRef
82.
go back to reference Krohn K, Stricker I, Emmrich P et al (2003) Cold thyroid nodules show a marked increase of proliferation markers. Thyroid 13:569–576PubMedCrossRef Krohn K, Stricker I, Emmrich P et al (2003) Cold thyroid nodules show a marked increase of proliferation markers. Thyroid 13:569–576PubMedCrossRef
83.
go back to reference Bol S, Belge G, Thode B et al (1999) Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature. Cancer Genet Cytogenet 114:75–77PubMedCrossRef Bol S, Belge G, Thode B et al (1999) Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature. Cancer Genet Cytogenet 114:75–77PubMedCrossRef
84.
go back to reference Rippe V, Drieschner N, Meiboom M et al (2003) Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas. Oncogene 22:6111–6114PubMedCrossRef Rippe V, Drieschner N, Meiboom M et al (2003) Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas. Oncogene 22:6111–6114PubMedCrossRef
85.
go back to reference Ward LS, Brenta G, Medvedovic M et al (1998) Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab 83:525–530PubMedCrossRef Ward LS, Brenta G, Medvedovic M et al (1998) Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab 83:525–530PubMedCrossRef
Metadata
Title
Molecular pathogenesis of nodular goiter
Author
Ralf Paschke
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 8/2011
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-011-0788-5

Other articles of this Issue 8/2011

Langenbeck's Archives of Surgery 8/2011 Go to the issue